Comparison of methodologies for evaluating regional intestinal permeability

Advances in Experimental Medicine and Biology

Volumn 423, Issue , 1997, Pages 181-189

  Raoof, A ^a   Moriarty, D ^a   Brayden, D ^a   Corrigan, O I ^b   Cumming, I ^a   Butler, J ^a   Devane, J ^a  

^a ELAN PHARMACEUTICALS   (United States)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DRUG ABSORPTION; DRUG PENETRATION; INTERMETHOD COMPARISON; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; MODEL; NONHUMAN; PHARMACEUTICS; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030788393     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4684-6036-0_16     Document Type: Article

References (25)

1. Rowland M. and Tozer T. Absorption. In Clinical Pharmacokinetics: concepts and applications. Lea and Febiger, Philadelphia, pp. 113-147, 1989.
2. Overton E. Ueber die allgemeinen osmotischen Eigenschaften der Zelle, ihre vermutlichen Ursachen und ihre Bedeutung fur die Physiologie. Viertelijahrsschr. Naturforsch. Ges. Zuerich, 44:88-135, 1899.
3. Audus K. and Raub T. Barriers to protein delivery. Plenum, New York, 1993.
4. Hillgren K., Kato A. and Borchardt R. In vitro systems for studying intestinal drug absorption. Medicinal Research Reviews, 15:83-109, 1995.
5. Dressman J. and Fleisher D. Mixing-tank model for predicting dissolution rate control of oral absorption. Journal of Pharmaceutical Sciences.75:109-116, 1986.
6. Powell D. Intestinal water and electrolyte transport. In Physiology of the gastrointestinal tract. (Johnson R., ed), Raven Press, New York, pp. 1267-1306, 1987.
7. Park G. and Mitra A. Mechanism and site dependency of intestinal mucosal transport and metabolism of thymidine analogues. Pharmaceutical Research. 9:326-331, 1992.
8. Seta Y, Higuchi F., Kawahara Y., Nishimura K. and Okada R. Design and preparation of captopril sustained-release dosage forms and their biopharmaceutical properties. International Journal of Pharmaceutics. 41:245-254, 1988.
9. Staib AH., Beermann D., Harder S., Fuhr U. and Liermann D. Absorption differences of ciprofloxacine along the human gastrointestinal tract determined using a remote-control drug delivery device (HF-capsule). American Journal of Medicine. 30:66S-69S, 1989.
10. Barr W., Zola E., Candler EL., Hang S., Tendolkar A., Shamburek R., Parker B. and Hilty M. Differential absorption of amoxacillin from human small and large intestine. Clinical Pharmacology and Therapeutics. 56:279-285, 1994.
11. Johnson L. Physiology of the gastrointestinal tract. Raven Press, New York, 1994.
12. Steed K. and Wilson C. Drug delivery to the large intestine. In: Physiological pharmaceutics: biological barriers to drug absorption. (Wilson C. and Washington N., ed.), Ellis Horwood, Chichester, pp. 91-108, 1989.
13. Lennemas H. Gastrointestinal absorption mechanisms: a comparison between animal and human models. European Journal of Pharmaceutical Sciences. 2:39-43, 1994.
14. Anderberg E. and Artursson P. Cell cultures to access drug absorption enhancement. In drug absorption enhancement concepts, possibilities, limitations and treads. (De Boer A., ed), Harwood Publishers, pp. 101-118, 1994.
15. Roy A., Curtis G. and Hughes H. The uptake of oestrone from the lumen of the isolated perfused rat gut. Xenobiotica. 21:491-498, 1991.
16. Komiya I., Park JY., Kamani A., HO NHF. and Higuchi W. Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes. International Journal of Pharmaceutics. 4:249-262, 1980.
17. Hirtz J. British Journal of Clinical Pharmacology. 19:77S-83S, 1985.
18. Artursson P. Epithelial transport of drugs in cell culture. I: a model for studying the passive diffusion of drugs over intestinal absorption (caco-2) cells. Journal of Pharmaceutical Sciences. 79:476-482, 1990.
19. Kararli T. Comparison of the gastrointestinal anatomy, physiology and biochemistry of humans and commonly used laboratory animals. Biopharmaceutics and Drug Disposition. 16:351-380, 1995.
20. Amidon G., Kou J., Elliott R. and Lightfoot E. Analysis of models for determining intestinal wall permeabilities. Journal of Pharmaceutical Sciences. 69:1369-1373, 1980.
21. Fagerholm U., Johansson M. and Lennernas H. Comparison between permeability coefficients in rat and human jejunum. Pharmaceutical Research. 13:1336-1342, 1996.
22. Para J. Colonic drug absorption and metabolism in novel drug delivery and its therapeutic applications. (Prescott L. and Nimmo W., ed), John Wiley & Sons Ltd, 1989.
23. Ilett K., Tee L., Reeves P. and Minchin R. Metabolism of drugs and other xenobiotics in the gut lumen and wall. Pharmacology and Therapeutics. 46:67-93, 1990.
24. Krishina D. and Klotz U. Extrahepatic metabolism of drugs in humans. Clinical Pharmacokinetics. 26:144-160, 1994.
25. Hu M., Li.,Ha H., Crespi L. and Huang, S. Drug metabolism by transfected Caco-2 cells expressing CYP3A4: comparison studies. Pharmaceutical Research. 13: S237, 1996